Cullinan Therapeutics, Inc. (CGEM) shares outstanding

Shares outstanding · fiscal 2025
59.00M

Cullinan Therapeutics, Inc. (CGEM) had 59.00M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 9.7% higher than the 53.77M of fiscal 2024. Figures as of 18 Nov 2026, 12:30 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Shares outstanding, fiscal 2025
59.00M
Change on fiscal 2024
+9.7%
Highest on record
59.00Mfiscal 2025
Lowest on record
41.55Mfiscal 2023
Fiscal years on record
52021–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Cullinan Therapeutics, Inc. shares outstanding, in more detail

The market data feed counts 64.92M shares outstanding today.

Across the 5 fiscal years on record (2021–2025), the highest was 59.00M in fiscal 2025 and the lowest 41.55M in fiscal 2023.

History · 5 fiscal years

Shares outstanding by fiscal year

Cullinan Therapeutics, Inc. shares outstanding, year by year

Cullinan Therapeutics, Inc. (CGEM) shares outstanding by fiscal year
Fiscal yearShares outstandingChangeYear ended
202559.00M 9.7% up
202453.77M 29.4% up
202341.55M 10.9% down
202246.64M 8.3% up
202143.08M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.

How to read it

A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.

More on CGEM

Cullinan Therapeutics, Inc., figure by figure

Cullinan Therapeutics, Inc. (CGEM) overview: price, valuation and scorecard

Cullinan Therapeutics, Inc. shares outstanding: questions and answers

How many shares does Cullinan Therapeutics, Inc. have?

Cullinan Therapeutics, Inc. (CGEM) had 59.00M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 9.7% higher than the 53.77M of fiscal 2024. The market data feed counts 64.92M shares outstanding today.

What are the highest and lowest diluted share count figures on record for Cullinan Therapeutics, Inc.?

Across the 5 fiscal years on record (2021–2025), the highest was 59.00M in fiscal 2025 and the lowest 41.55M in fiscal 2023.

How is Cullinan Therapeutics, Inc.'s diluted share count calculated?

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed. For Cullinan Therapeutics, Inc. it is on record here for 5 fiscal years, 2021 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Cullinan Therapeutics, Inc. (CGEM) shares outstanding”, data as of 18 November 2026. https://funkfolio.com/stock/CGEM/shares-outstanding

Underlying data: the company's filings with the SEC and Yahoo Finance.